pyridoxine has been researched along with Basal Ganglia Diseases in 6 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In addition to current treatment of both basic disease and adverse effects, cerebrolysin was administered (5-10 ml i." | 1.30 | [Cerebrolysin and magnesium-B6 in the treatment of side effects of psychotropic drugs]. ( Bondar', VV; Krasnikova, NI; Panteleeva, GP; Raiushkin, VA, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ALLEVA, PM | 1 |
| GRINSCHGL, G | 1 |
| Brooks, SC | 1 |
| D'Angelo, L | 1 |
| Chalmeta, A | 1 |
| Ahern, G | 1 |
| Judson, JH | 1 |
| Panteleeva, GP | 1 |
| Bondar', VV | 1 |
| Krasnikova, NI | 1 |
| Raiushkin, VA | 1 |
| Park, J | 1 |
| Logan, R | 1 |
| Pottage, A | 1 |
| Tkachev, RA | 1 |
| Markova, ED | 1 |
| Gotovtseva, EV | 1 |
| Barkhatova, VP | 1 |
| Ivanova-Smolenskaia, IA | 1 |
6 other studies available for pyridoxine and Basal Ganglia Diseases
| Article | Year |
|---|---|
[On the therapeutic effects of high doses of pyridoxine in extrapyramidal syndromes].
Topics: Basal Ganglia Diseases; Parkinson Disease; Pyridoxine; Spasm; Syndrome; Vitamin B 6 | 1960 |
[Vitamin B6 (pyridoxine) and its therapeutic mode of action, with special reference to extrapyramidal disorders].
Topics: Basal Ganglia Diseases; Disease; Extrapyramidal Tracts; Humans; Pyridoxine; Vitamin B 6 | 1951 |
An unusual schizophrenic illness responsive to pyridoxine HCl (B6) subsequent to phenothiazine and butyrophenone toxicities.
Topics: Acute Disease; Adolescent; Basal Ganglia Diseases; Drug Administration Schedule; Follow-Up Studies; | 1983 |
[Cerebrolysin and magnesium-B6 in the treatment of side effects of psychotropic drugs].
Topics: Adolescent; Adult; Amino Acids; Basal Ganglia Diseases; Female; Humans; Magnesium; Male; Middle Aged | 1999 |
Drug-induced extrapyramidal signs in chronic liver disease--a case report.
Topics: Basal Ganglia Diseases; Chronic Disease; Drug Combinations; Female; Humans; Liver Diseases; Meclizin | 1977 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphe | 1973 |